Market Overview on Imaging Biomarkers Market - Global Industry Analysis, Market Size, Share, Growth, Trends & Forecasts 2013 - 2019

Submitted by: Submitted by

Views: 98

Words: 919

Pages: 4

Category: Business and Industry

Date Submitted: 07/09/2014 03:47 AM

Report This Essay

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Imaging Biomarkers Market". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure.

Biomarkers also known as biological markers are characteristics that are measured in order to assess and predict biological condition of the body and thus help physicians in clinical decision making. Some major diseases which are diagnosed by using biomarkers include diabetes, cancer and cardiovascular and central nervous system diseases. Biomarkers play critical role in identifying and accurate diagnosis of these diseases at early stage and provide better treatment option. Imaging biomarkers can be classified as diagnostic biomarkers, monitoring biomarkers and predictive biomarkers. Diagnostic biomarkers are helpful in predicting a patient’s exact clinical outcome. Monitoring biomarkers provides clinical outcome of a patient after intake of a particular drug while predictive biomarkers help in predicting if a specific drug is likely to change clinical outcome of a patient.

Browse Full Report with TOC:

Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Affymetrix Inc., Danaher Corporation, Bio-Rad Laboratories Inc., F. Hoffmann La Roche Ltd., Gen-Probe Inc., DiagnoCure Inc., and Siemens Healthcare are some major companies operating in the imaging biomarkers market and compete with each other in order to get competitive advantage. Small companies with breakthrough technologies attract large players to form alliances and thus help them gain advantages over their competitors.

Globally, the market for imaging biomarkers is evolving due to its increasing popularity and extensive use in drug discovery processes. The industry has witnessed a...